SCOTUS invites govt comment on Teva clash

04-10-2022

Staff writer

SCOTUS invites govt comment on Teva clash

shutterstock_2162525475_jonathan-weiss

The US Supreme Court has asked the US government to weigh in on whether the court should hear the ‘skinny-label’ dispute between Teva and GSK. 


Skinny labels, Federal Circuit, Teva, GSK, generic drug manufacturers, Teva Pharmaceuticals, Coreg, Hatch-Waxman Act, infringement, FDA, US, Big pharma

LSIPR